URGENT CALL TO ACTION!
DO NOT SEND Jamil Al-AMIN BACK TO SUPERMAX
For two months, Imam Jamil Al-Amin #99974-555 has undergone tests at Butner FMC in North Carolina.
Imam Jamil has smoldering myeloma, which is an inactive form of multiple myeloma. Individuals with smoldering myeloma generally are monitored without receiving treatment, although there are studies that indicate early intervention with medication could prevent the progression to active multiple myeloma.
Imam Jamil has smoldering myeloma, which is an inactive form of multiple myeloma. Individuals with smoldering myeloma generally are monitored without receiving treatment, although there are studies that indicate early intervention with medication could prevent the progression to active multiple myeloma.
The physicians at Butner FMC have not recommended that Imam Jamil receive any medication for his smoldering myeloma. They agree that he should be monitored and tested every two to three months to determine any progression of his condition. Imam Jamil has other medical conditions, which have not been addressed adequately at the Butner FMC.
2. Request that Jamil Al-Amin is held - pending his appeals at Butner, NC or a Georgia state facility to have access to his team of attorneys.
3. Request close monitoring and exploration of treatment for Jamil Al-Amin's medical conditions.
CALL AND E-MAIL THE FOLLOWING
Charles E. Samuels, Director, Federal Bureau of Prisons phone:202-307-3250
Dr. Newton E. Kendig, FBOP Medical Director
phone: 202-307-3055
e-mail: nkendig@bop.gov
Eric Holder, Attorney General, DOJ 202-514-2001
DOJ public comment line, 202-353-1555, or AskDOJ@usdoj.gov
Office of General Counsel, Kathleen M. Kenny
phone: 202-307-3062
The White House phone: 202-456-1414
www.bop.gov/inmates/concerns.jsp.
Select Butner FMC and #99974-555
Visit: www.hrapbrown.blogspot.com
No comments:
Post a Comment